AI Generated Image
Pancreatic cancer experts gather to discuss what comes after daraxonrasib
STAT • • health
Key Points:
- A pancreatic cancer conference in London was initially planned to complement a regular U.S. meeting for international experts to discuss advances in the field.
- The conference agenda was quickly adjusted following a major breakthrough in pancreatic cancer treatment, marking the most significant progress in decades.
- Oncologist Talia Golan highlighted the new drug's clinical trial results as a landmark moment, comparable to the introduction of checkpoint inhibitors in cancer therapy.
